Aripiprazole Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

It is formulated by 33 pharmaceutical companies such as OTSUKA PHARM CO LTD, TORRENT, TEVA PHARMS USA and others. It is marketed under 8 brand names, including ABILIFY MAINTENA KIT, ARIPIPRAZOLE, ARISTADA and others. Available in 18 different strengths, such as 300MG/VIAL, 400MG/VIAL, 400MG and others, and administered through 6 routes including FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR, TABLET;ORAL, TABLET, ORALLY DISINTEGRATING;ORAL and others.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 33 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"62102","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY","family_id":"58f45a6d57964793b483","publication_number":"US7550445B2","cleaned_patent_number":"7550445","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-21","publication_date":"2009-06-23","legal_status":"Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362"}	US7550445B2	23 Jun, 2009	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	21 Jan, 2025
{"application_id":"62071","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY","family_id":"58f45a6d57964793b483","publication_number":"US7115587B2","cleaned_patent_number":"7115587","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-01-21","publication_date":"2006-10-03","legal_status":"Granted"}	US7115587B2	03 Oct, 2006	Granted	21 Jan, 2025
{"application_id":"57582","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY ASIMTUFII","family_id":"51c3ae323dc64fe6a231","publication_number":"US8338427B2","cleaned_patent_number":"8338427","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-15","publication_date":"2012-12-25","legal_status":"Granted"}	US8338427B2 Formulation	25 Dec, 2012	Granted	15 Mar, 2025
{"application_id":"57773","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY ASIMTUFII","family_id":"f5746690204847a3b446","publication_number":"US8399469B2","cleaned_patent_number":"8399469","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-29","publication_date":"2013-03-19","legal_status":"Granted"}	US8399469B2 Molecular	19 Mar, 2013	Granted	29 Jun, 2025
{"application_id":"89250","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"20c7c18ebbb8414cb098","publication_number":"US11476952B2","cleaned_patent_number":"11476952","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-04-28","publication_date":"2022-10-18","legal_status":"Granted"}	US11476952B2 Formulation	18 Oct, 2022	Granted	28 Apr, 2026
{"application_id":"88676","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY","family_id":"77e88d14bf524cc4a854","publication_number":"US9125939B2","cleaned_patent_number":"9125939","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-28","publication_date":"2015-09-08","legal_status":"Granted"}	US9125939B2	08 Sep, 2015	Granted	28 Jul, 2026
{"application_id":"89218","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US7978064B2","cleaned_patent_number":"7978064","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-09-14","publication_date":"2011-07-12","legal_status":"Granted"}	US7978064B2 Formulation	12 Jul, 2011	Granted	14 Sep, 2026
{"application_id":"75961","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY","family_id":"70eee3446b704b06b0b1","publication_number":"US8759350B2","cleaned_patent_number":"8759350","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-03-02","publication_date":"2014-06-24","legal_status":"Granted"}	US8759350B2	24 Jun, 2014	Granted	02 Mar, 2027
{"application_id":"89302","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"f047b93459904b52bc99","publication_number":"US9444503B2","cleaned_patent_number":"9444503","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-19","publication_date":"2016-09-13","legal_status":"Granted"}	US9444503B2 Formulation	13 Sep, 2016	Granted	19 Nov, 2027
{"application_id":"89226","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US9119554B2","cleaned_patent_number":"9119554","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-12-16","publication_date":"2015-09-01","legal_status":"Granted"}	US9119554B2 Formulation	01 Sep, 2015	Granted	16 Dec, 2028
{"application_id":"89414","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"45631e00319e4b77868c","publication_number":"US9258035B2","cleaned_patent_number":"9258035","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-05","publication_date":"2016-02-09","legal_status":"Granted"}	US9258035B2 Formulation	09 Feb, 2016	Granted	05 Mar, 2029
{"application_id":"89441","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"45631e00319e4b77868c","publication_number":"US9060708B2","cleaned_patent_number":"9060708","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-03-05","publication_date":"2015-06-23","legal_status":"Granted"}	US9060708B2 Formulation	23 Jun, 2015	Granted	05 Mar, 2029
{"application_id":"89219","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US8674825B2","cleaned_patent_number":"8674825","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-04-09","publication_date":"2014-03-18","legal_status":"Granted"}	US8674825B2 Formulation	18 Mar, 2014	Granted	09 Apr, 2029
{"application_id":"89099","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"0fb125a934a948098195","publication_number":"US8956288B2","cleaned_patent_number":"8956288","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-06","publication_date":"2015-02-17","legal_status":"Granted"}	US8956288B2 Formulation	17 Feb, 2015	Granted	06 Jul, 2029
{"application_id":"89483","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"af780f3aedce44ed8d51","publication_number":"US10441194B2","cleaned_patent_number":"10441194","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-07-26","publication_date":"2019-10-15","legal_status":"Patented case"}	US10441194B2 Formulation	15 Oct, 2019	Patented case	26 Jul, 2029
{"application_id":"89018","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"aff18bfe24f94670b7db","publication_number":"US8945005B2","cleaned_patent_number":"8945005","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-08-19","publication_date":"2015-02-03","legal_status":"Granted"}	US8945005B2 Formulation	03 Feb, 2015	Granted	19 Aug, 2029
{"application_id":"89341","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"6988b633273a4213a753","publication_number":"US9433371B2","cleaned_patent_number":"9433371","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-09-15","publication_date":"2016-09-06","legal_status":"Granted"}	US9433371B2 Formulation	06 Sep, 2016	Granted	15 Sep, 2029
{"application_id":"89304","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"f047b93459904b52bc99","publication_number":"US8718193B2","cleaned_patent_number":"8718193","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-12-05","publication_date":"2014-05-06","legal_status":"Granted"}	US8718193B2 Formulation	06 May, 2014	Granted	05 Dec, 2029
{"application_id":"89394","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"bf15605697434e90b3cc","publication_number":"US9149577B2","cleaned_patent_number":"9149577","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-12-15","publication_date":"2015-10-06","legal_status":"Granted"}	US9149577B2 Formulation	06 Oct, 2015	Granted	15 Dec, 2029
{"application_id":"89224","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US8847766B2","cleaned_patent_number":"8847766","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-29","publication_date":"2014-09-30","legal_status":"Patented case"}	US8847766B2 Formulation	30 Sep, 2014	Patented case	29 Mar, 2030
{"application_id":"89310","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"fc32a03f4188473a9a65","publication_number":"US8545402B2","cleaned_patent_number":"8545402","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-27","publication_date":"2013-10-01","legal_status":"Patented case"}	US8545402B2 Formulation	01 Oct, 2013	Patented case	27 Apr, 2030
{"application_id":"89347","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"bf15605697434e90b3cc","publication_number":"US8114021B2","cleaned_patent_number":"8114021","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-21","publication_date":"2012-02-14","legal_status":"Granted"}	US8114021B2 Formulation	14 Feb, 2012	Granted	21 Jun, 2030
{"application_id":"82003","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"2e73e2f44ffa464abaa9","publication_number":"US8796276B2","cleaned_patent_number":"8796276","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-24","publication_date":"2014-08-05","legal_status":"Granted"}	US8796276B2	05 Aug, 2014	Granted	24 Jun, 2030
{"application_id":"82043","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"2e73e2f44ffa464abaa9","publication_number":"US10112903B2","cleaned_patent_number":"10112903","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-24","publication_date":"2018-10-30","legal_status":"Granted"}	US10112903B2 Molecular	30 Oct, 2018	Granted	24 Jun, 2030
{"application_id":"89112","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"c13c097af1ee4a6d9b6d","publication_number":"US11464423B2","cleaned_patent_number":"11464423","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-09-15","publication_date":"2022-10-11","legal_status":"Granted"}	US11464423B2 Formulation	11 Oct, 2022	Granted	15 Sep, 2030
{"application_id":"82038","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"2e73e2f44ffa464abaa9","publication_number":"US8431576B2","cleaned_patent_number":"8431576","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-26","publication_date":"2013-04-30","legal_status":"Granted"}	US8431576B2 Molecular	30 Apr, 2013	Granted	26 Oct, 2030
{"application_id":"89444","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"151c7cb33f2e41e184b0","publication_number":"US9941931B2","cleaned_patent_number":"9941931","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-04","publication_date":"2018-04-10","legal_status":"Granted"}	US9941931B2 Formulation	10 Apr, 2018	Granted	04 Nov, 2030
{"application_id":"89344","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"6988b633273a4213a753","publication_number":"US8961412B2","cleaned_patent_number":"8961412","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-17","publication_date":"2015-02-24","legal_status":"Granted"}	US8961412B2 Formulation	24 Feb, 2015	Granted	17 Nov, 2030
{"application_id":"89438","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"45631e00319e4b77868c","publication_number":"US8258962B2","cleaned_patent_number":"8258962","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-25","publication_date":"2012-09-04","legal_status":"Granted"}	US8258962B2 Formulation	04 Sep, 2012	Granted	25 Nov, 2030
{"application_id":"89116","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US8547248B2","cleaned_patent_number":"8547248","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-18","publication_date":"2013-10-01","legal_status":"Granted"}	US8547248B2 Formulation	01 Oct, 2013	Granted	18 Dec, 2030
{"application_id":"89241","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US11229378B2","cleaned_patent_number":"11229378","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-07-11","publication_date":"2022-01-25","legal_status":"Granted"}	US11229378B2 Formulation	25 Jan, 2022	Granted	11 Jul, 2031
{"application_id":"89333","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"fc32a03f4188473a9a65","publication_number":"US9320455B2","cleaned_patent_number":"9320455","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-12-15","publication_date":"2016-04-26","legal_status":"Granted"}	US9320455B2 Formulation	26 Apr, 2016	Granted	15 Dec, 2031
{"application_id":"81997","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"da03e299e24b4b3385f8","publication_number":"US10226458B2","cleaned_patent_number":"10226458","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-19","publication_date":"2019-03-12","legal_status":"Granted"}	US10226458B2	12 Mar, 2019	Granted	19 Mar, 2032
{"application_id":"89236","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"823a52ad36d141b0aa47","publication_number":"US10517507B2","cleaned_patent_number":"10517507","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-06-13","publication_date":"2019-12-31","legal_status":"Granted"}	US10517507B2 Formulation	31 Dec, 2019	Granted	13 Jun, 2032
{"application_id":"81961","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"da03e299e24b4b3385f8","publication_number":"US9034867B2","cleaned_patent_number":"9034867","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-07","publication_date":"2015-05-19","legal_status":"Granted"}	US9034867B2 Formulation	19 May, 2015	Granted	07 Nov, 2032
{"application_id":"124167","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY ASIMTUFII","family_id":"","publication_number":"US12016927B2","cleaned_patent_number":"12016927","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-23","publication_date":"2024-06-25","legal_status":"Granted"}	US12016927B2 Formulation	25 Jun, 2024	Granted	23 Apr, 2033
{"application_id":"116274","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY ASIMTUFII","family_id":"e7bf22f2206d48d9955b","publication_number":"US10517951B2","cleaned_patent_number":"10517951","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-23","publication_date":"2019-12-31","legal_status":"Granted"}	US10517951B2 Formulation	31 Dec, 2019	Granted	23 Apr, 2033
{"application_id":"116275","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY ASIMTUFII","family_id":"e7bf22f2206d48d9955b","publication_number":"US11097007B2","cleaned_patent_number":"11097007","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-23","publication_date":"2021-08-24","legal_status":"Granted"}	US11097007B2 Formulation	24 Aug, 2021	Granted	23 Apr, 2033
{"application_id":"116220","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY ASIMTUFII","family_id":"e7bf22f2206d48d9955b","publication_number":"US11638757B2","cleaned_patent_number":"11638757","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-23","publication_date":"2023-05-02","legal_status":"Granted"}	US11638757B2 Formulation	02 May, 2023	Granted	23 Apr, 2033
{"application_id":"242101","ingredient":"ARIPIPRAZOLE","trade_name":"MEZOFY","family_id":"","publication_number":"US9694008B2","cleaned_patent_number":"9694008","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-08-07","publication_date":"2017-07-04","legal_status":"Granted"}	US9694008B2 Formulation	04 Jul, 2017	Granted	07 Aug, 2033
{"application_id":"57618","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MAINTENA KIT","family_id":"581d5fca066c4ab893ca","publication_number":"US11344547B2","cleaned_patent_number":"11344547","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-09-24","publication_date":"2022-05-31","legal_status":"Granted"}	US11344547B2	31 May, 2022	Granted	24 Sep, 2033
{"application_id":"57616","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MAINTENA KIT","family_id":"581d5fca066c4ab893ca","publication_number":"US10980803B2","cleaned_patent_number":"10980803","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-09-24","publication_date":"2021-04-20","legal_status":"Granted"}	US10980803B2	20 Apr, 2021	Granted	24 Sep, 2033
{"application_id":"57619","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MAINTENA KIT","family_id":"581d5fca066c4ab893ca","publication_number":"US11400087B2","cleaned_patent_number":"11400087","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-09-24","publication_date":"2022-08-02","legal_status":"Granted"}	US11400087B2	02 Aug, 2022	Granted	24 Sep, 2033
{"application_id":"57617","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MAINTENA KIT","family_id":"581d5fca066c4ab893ca","publication_number":"US11154553B1","cleaned_patent_number":"11154553","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-09-24","publication_date":"2021-10-26","legal_status":"Granted"}	US11154553B2	26 Oct, 2021	Granted	24 Sep, 2033
{"application_id":"89282","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MYCITE KIT","family_id":"9205458987904f81b028","publication_number":"US9268909B2","cleaned_patent_number":"9268909","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-15","publication_date":"2016-02-23","legal_status":"Granted"}	US9268909B2 Formulation	23 Feb, 2016	Granted	15 Oct, 2033
{"application_id":"81941","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"cbebe35cb212412fb9b8","publication_number":"US9193685B2","cleaned_patent_number":"9193685","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-24","publication_date":"2015-11-24","legal_status":"Granted"}	US9193685B2 Formulation	24 Nov, 2015	Granted	24 Oct, 2033
{"application_id":"81956","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"cbebe35cb212412fb9b8","publication_number":"US11097006B2","cleaned_patent_number":"11097006","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-24","publication_date":"2021-08-24","legal_status":"Granted"}	US11097006B2 Formulation	24 Aug, 2021	Granted	24 Oct, 2033
{"application_id":"57615","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MAINTENA KIT","family_id":"581d5fca066c4ab893ca","publication_number":"US10525057B2","cleaned_patent_number":"10525057","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-08","publication_date":"2020-01-07","legal_status":"Granted"}	US10525057B2	07 Jan, 2020	Granted	08 Mar, 2034
{"application_id":"115037","ingredient":"ARIPIPRAZOLE","trade_name":"ABILIFY MAINTENA KIT","family_id":"a8068b9cfffe46ff8423","publication_number":"US11648347B2","cleaned_patent_number":"11648347","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-04-06","publication_date":"2023-05-16","legal_status":"Granted"}	US11648347B2 Formulation	16 May, 2023	Granted	06 Apr, 2034
{"application_id":"81936","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US10238651B2","cleaned_patent_number":"10238651","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2019-03-26","legal_status":"Granted"}	US10238651B2	26 Mar, 2019	Granted	19 Mar, 2035
{"application_id":"81938","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US11406632B2","cleaned_patent_number":"11406632","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2022-08-09","legal_status":"Granted"}	US11406632B2	09 Aug, 2022	Granted	19 Mar, 2035
{"application_id":"81937","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US10813928B2","cleaned_patent_number":"10813928","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2020-10-27","legal_status":"Granted"}	US10813928B2	27 Oct, 2020	Granted	19 Mar, 2035
{"application_id":"81917","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US9452131B2","cleaned_patent_number":"9452131","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2016-09-27","legal_status":"Granted"}	US9452131B2	27 Sep, 2016	Granted	19 Mar, 2035
{"application_id":"81934","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US9526726B2","cleaned_patent_number":"9526726","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2016-12-27","legal_status":"Granted"}	US9526726B2 Formulation	27 Dec, 2016	Granted	19 Mar, 2035
{"application_id":"82067","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US10849894B2","cleaned_patent_number":"10849894","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-17","publication_date":"2020-12-01","legal_status":"Granted"}	US10849894B2	01 Dec, 2020	Granted	17 Aug, 2035
{"application_id":"82105","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US10688091B2","cleaned_patent_number":"10688091","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-17","publication_date":"2020-06-23","legal_status":"Granted"}	US10688091B2 Formulation	23 Jun, 2020	Granted	17 Aug, 2035
{"application_id":"82106","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US11154552B2","cleaned_patent_number":"11154552","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-17","publication_date":"2021-10-26","legal_status":"Granted"}	US11154552B2 Formulation	26 Oct, 2021	Granted	17 Aug, 2035
{"application_id":"82104","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US10016415B2","cleaned_patent_number":"10016415","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-09-08","publication_date":"2018-07-10","legal_status":"Granted"}	US10016415B2 Formulation	10 Jul, 2018	Granted	08 Sep, 2035
{"application_id":"82058","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"df1c48fadcde4cb8af24","publication_number":"US11273158B2","cleaned_patent_number":"11273158","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-06","publication_date":"2022-03-15","legal_status":"Granted"}	US11273158B2	15 Mar, 2022	Granted	06 Apr, 2039
{"application_id":"82064","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"df1c48fadcde4cb8af24","publication_number":"US20220152021A1","cleaned_patent_number":"12251381","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-09","publication_date":"2022-05-19","legal_status":"Pending"}	US12251381B2	19 May, 2022	Pending	09 Apr, 2039
{"application_id":"138451","ingredient":"ARIPIPRAZOLE","trade_name":"OPIPZA","family_id":"","publication_number":"US11331315B2","cleaned_patent_number":"11331315","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-11-03","publication_date":"2022-05-17","legal_status":"Granted"}	US11331315B2 Formulation	17 May, 2022	Granted	03 Nov, 2040
{"application_id":"138452","ingredient":"ARIPIPRAZOLE","trade_name":"OPIPZA","family_id":"","publication_number":"US11701352B2","cleaned_patent_number":"11701352","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-12-15","publication_date":"2023-07-18","legal_status":"Granted"}	US11701352B2 Formulation	18 Jul, 2023	Granted	15 Dec, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Aripiprazole

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.